DS06652923
DS06652923 is a potent, orally bioavailable small molecule inhibitor targeting EGFR triple mutations. It demonstrates strong in vitro activity with a GI50 of 9.4 nM in Ba/F3-EGFRdel19/T790M/C795S cells and has shown efficacy in vivo by inducing tumor regression in a syngeneic transplantation model, supporting its use in oncology research for resistant NSCLC.
Product Specifications
Field of Research
Cardiovascular Research, Signal Transduction
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1320403-01 0.02 mg (E-Coli)
Recombinant Bovine N-acylneuraminate cytidylyltransferase (CMAS)
Sign In for Pricing
View Details MBS1320403-02 0.02 mg (Yeast)
Recombinant Bovine N-acylneuraminate cytidylyltransferase (CMAS)
Sign In for Pricing
View Details MBS1320403-03 0.1 mg (E-Coli)
Recombinant Bovine N-acylneuraminate cytidylyltransferase (CMAS)
Sign In for Pricing
View Details MBS1320403-04 0.1 mg (Yeast)
Recombinant Bovine N-acylneuraminate cytidylyltransferase (CMAS)
Sign In for Pricing
View Details MBS1320403-05 0.02 mg (Baculovirus)
Recombinant Bovine N-acylneuraminate cytidylyltransferase (CMAS)
Sign In for Pricing
View Details